Angels for Change applauds Senator Kaine, Senator Cotton, Representative Spanberger, and Representative Smith for their bipartisan leadership in taking on the drug shortage crisis and advancing this vital work. We are proud to support the End Drug Shortages Act.
How Pharmaceutical Supply Chain Advancements are Meeting the Moment and Beyond panel at Milken Institute Future of Health Summit, moderated by Sarah Karlin-Smith from Citeline, with Panelists Laura Bray from Angels for Change, Shamiram Feinglass MD, MPH from Manatt, Phelps & Phillips, LLP, Kirk Kaminsky from McKesson and Vimala Raghavendran from US Pharmacopeia.
Angels for Change is proud to announce a significant milestone in Project PROTECT. Fagron Sterile Services US (FSS), a recipient of the 2023 Project PROTECT grant and a leader 503B outsourcing, has completed the Preparation and Protective phases for preservative-free Dextrose 70% injection solution. The significance of this achievement is highlighted by the recent flooding at Baxter's North Cove manufacturing site due to Hurricane Helene, which prompted the U.S. Food and Drug Administration to include Dextrose on its drug shortage list as of October 12, 2024. The strategic preparations made through Project PROTECT, Dextrose will remain accessible to vulnerable patients, especially PICU and NICU babies, amid anticipated supply chain disruptions.
How Pharmaceutical Supply Chain Advancements are Meeting the Moment and Beyond panel at Milken Institute Future of Health Summit, moderated by Sarah Karlin-Smith from Citeline, with Panelists Laura Bray from Angels for Change, Shamiram Feinglass MD, MPH from Manatt, Phelps & Phillips, LLP, Kirk Kaminsky from McKesson and Vimala Raghavendran from US Pharmacopeia.
Thank you Fierce Healthcare for highlighting our work on the new White House Cancer Moonshot pilot to mitigate pediatric cancer drug shortages. The End Drug Shortages Alliance will coordinate participating healthcare providers, including Children’s Hospital of Philadelphia, Children’s National Hospital, Children’s Mercy Kansas City, Cincinnati Children’s Hospital Medical Center, Stanford Medicine Children’s Health, St. Jude Children’s Research Hospital, and Texas Children’s Hospital; pharmaceutical wholesalers, Cencora and Morris & Dickson; and advising partners Angels for Change, Children’s Hospital Association, and US Pharmacopeia. The pilot will launch before the end of the year and run into 2025.
Becker’s Healthcare spotlights the new White House Cancer Moonshot pilot aimed at mitigating pediatric cancer drug shortages.
“Healthcare providers participating in the pilot program are Children's Hospital of Philadelphia, Washington, D.C. - based Children's National Hospital, Children's Mercy Kansas City (Mo.), Cincinnati Children's Hospital Medical Center, Stanford (Calif.) Medicine Children's Health, Memphis, Tenn.-based St. Jude Children's Research Hospital and Houston-based Texas Children's Hospital. Pharmaceutical companies Cencora and Morris & Dickson, and nonprofit organizations Angels for Change, the Children's Hospital Association and US Pharmacopeia will also participate.” wrote Elizabeth Gregerson
[October 28th, 2024] Today, the White House announced a new pilot program under Biden Cancer Moonshot. Angels for Change is honored to be the trusted patient voice on this group-breaking initiative. We would like to thank all pilot members and the End Drug Shortages Alliance for joining this collaborative patient-focused work.
“This pilot program builds on the work the Biden Cancer Moonshot has led to ensure that children and families facing cancer have equitable resources and access to diagnosis, treatment, research, and survivorship care” - Office of Science and Technology Policy (Oct. 28, 2024). Biden Cancer Moonshot Announces New Pilot to Mitigate Pediatric Cancer Drug Shortages
Thank you to the Wall Street Journal for bringing awareness to this project and for highlighting Blanca Alvarado, Mother of Shortage Warrior Giana.
“It’s scary to not know what we’re going to be facing tomorrow,” Alvarado said.
